Teriparatide · source year
5 selected, source-linked Teriparatide records carrying a 2011 source date. This is a navigational view of PeptideScanner’s selected coverage—not a complete research timeline or a statement about safety or effectiveness.
5 selected records.
1 represented type.
5 distinct public records.
Cited chronology
Clinical trials
PeptideScanner retained ClinicalTrials.gov record NCT00557310 at 2026-07-30T22:15:58.883Z. Its registry update date was 2011-11-11, and PeptideScanner's reviewed identity mapping was teriparatide.
Source: ClinicalTrials.gov ↗
Clinical trials
PeptideScanner retained ClinicalTrials.gov record NCT00761332 at 2026-07-30T22:15:58.887Z. Its registry update date was 2011-06-21, and PeptideScanner's reviewed identity mapping was teriparatide.
Source: ClinicalTrials.gov ↗
Clinical trials
PeptideScanner retained ClinicalTrials.gov record NCT00343252 at 2026-07-30T22:15:58.895Z. Its registry update date was 2011-05-26, and PeptideScanner's reviewed identity mapping was teriparatide.
Source: ClinicalTrials.gov ↗
Clinical trials
PeptideScanner retained ClinicalTrials.gov record NCT00696644 at 2026-07-30T22:15:58.886Z. Its registry update date was 2011-05-09, and PeptideScanner's reviewed identity mapping was teriparatide.
Source: ClinicalTrials.gov ↗
Clinical trials
PeptideScanner retained ClinicalTrials.gov record NCT00439244 at 2026-07-30T22:15:58.884Z. Its registry update date was 2011-04-20, and PeptideScanner's reviewed identity mapping was teriparatide.
Source: ClinicalTrials.gov ↗